Elsevier

Journal of Controlled Release

Volume 193, 10 November 2014, Pages 257-269
Journal of Controlled Release

Review
Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery

https://doi.org/10.1016/j.jconrel.2014.04.045Get rights and content

Abstract

Transdermal drug delivery is hindered by the barrier property of the stratum corneum. It limits the route to transport of drugs with a log octanol–water partition coefficient of 1 to 3, molecular weight of less than 500 Da and melting point of less than 200 °C. Active methods such as iontophoresis, electroporation, sonophoresis, magnetophoresis and laser techniques have been investigated for the past decades on their ability, mechanisms and limitations in modifying the skin microenvironment to promote drug diffusion and partition. Microwave, an electromagnetic wave characterized by frequencies range between 300 MHz and 300 GHz, has recently been reported as the potential skin permeation enhancer. Microwave has received a widespread application in food, engineering and medical sectors. Its potential use to facilitate transdermal drug transport is still in its infancy stage of evaluation. This review provides an overview and update on active methods utilizing electrical, magnetic, photomechanical and cavitational waves to overcome the skin barrier for transdermal drug administration with insights into mechanisms and future perspectives of the latest microwave technique described.

Introduction

Skin comprises approximately 15% of the total adult body weight and has a surface area about 2 m2 [1]. The stratum corneum is the outermost layer of skin and the principal barrier to molecular transport across the skin and into the systemic circulation (Fig. 1) [2]. The stratum corneum consists of 10 to 15 layers of anucleated corneocytes (polygonal, elongated and flat; 0.2 to 1.5 μm thick; 34 to 46 μm wide) with thickness varying between 10 and 15 μm in dry state and 40 μm in hydration state [2], [3]. These corneocytes are filled with a matrix of crosslinked keratin fibers which are negatively charged at physiological conditions and responsible for the mechanical build up of the stratum corneum [4]. The keratin-rich corneocytes are arranged in brick-and-mortar like structure with intercellular matrix made of long chain ceramides, free fatty acids, triglycerides, cholesterol, cholesterol sulfate and sterol/wax esters, and intercellular spaces occupying 5 to 20% of the volume of stratum corneum [2], [3], [5]. The lipid lamellae are associated into lipid bilayer with hydrocarbon chains arranged in crystalline, lamellar gel and lamellar liquid crystal phases, and polar head groups into aqueous phase. The pH of skin surface is about 5 [4]. With pKa values of approximately 8, the head groups of stratum corneum lipids only ionize to a small extent. The physiological pH rises to 7.4 in deeper layers of stratum corneum. A greater population of lipids in this region is ionized with fatty acids of pKa between 4.8 and 6.3 responsible for negative net charge of skin.

Beneath the stratum corneum and epidermal layers is the dermis [1]. The dermis is thicker (approximately 1 to 4 mm) than the epidermis. The main extracellular matrix components of the dermis are collagen and elastin fibers. In the dermis, both blood capillaries and nerve endings are embedded [6].

Section snippets

Transdermal drug delivery

Trandermal drug delivery is mediated through direct transfer across the stratum corneum, through the sweat glands, or via hair follicles and sebaceous glands (shunt or appendageal route) [3]. It is recognized that appendages occupy an area for surface permeation of approximately 0.1% [3]. Their contribution to transdermal drug permeation can be minimal except in iontophoresis whereby electrical charges are used to drive the drug molecules into the skin via shunt routes as they provide less

Iontophoresis

Iontophoresis refers to a process whereby low amplitude electrical currents (0.5 mA/cm2) are applied on skin for minutes or hours to promote transdermal drug delivery (Fig. 2) [1], [3], [16], [17], [18]. Examples of drugs include charged and neutral molecules, as well as, low and high molecular weight drugs namely lidocaine [19], dexamethasone [20], piroxicam [21], diclofenac [21], ranitidine [22], donepezil [23], almotriptan [24], insulin [21], calcitonin [21] and luteinizing hormone-releasing

Electroporation

Electroporation utilizes short, high-voltage electrical pulses (50 to 1500 V) to promote transdermal drug delivery, typically tens to hundreds of volts for microseconds to milliseconds with intervals between pulses of a few seconds to a minute [1], [3], [14], [17]. The transdermal drug delivery increases with a rise in pulse voltage, number, duration and rate [14]. Electroporation of lipid bilayers results in phase transition and fluidization of lipids due to joule heating and localized

Sonophoresis/phonophoresis

Ultrasound of a wide ranging frequency between 20 kHz and 16 MHz with an amplitude between 1 and 5 bar for the order of tens of minutes is used in sonophoresis or phonophoresis [5], [17]. Sonophoresis can be broadly classified into three categories [7], [17]:

  • 1.

    Low frequency 20 kHz to 100 kHz.

  • 2.

    Therapeutic frequency 1 MHz to 3 MHz.

  • 3.

    High frequency 2 MHz to 16 MHz.

High frequency ultrasound is less associated with the applications for systemic delivery and only a limited number of drugs with molecular weight

Magnetophoresis

Magnetophoresis exploits a magnetic field (5 to 300 mT) to enhance transdermal drug delivery where diamagnetic drugs such as lidocaine can be repelled away from the magnetic field and migrated into the skin (Fig. 4a) [1], [7], [63]. The magnetophoretic drug permeation “flux enhancement factor” increases with an increase in the magnetic field strength [63]. The transdermal drug permeation is enhanced through modulating the permeability of stratum corneum [64].

Unlike iontophoresis, electroporation

Laser

Lasers are broadband, unipolar and compressible photomechanical waves (Fig. 4b) [7]. Unlike ultrasound, the photomechanical waves are characterized only by positive pressure and it has no negative pressure (tensile component) which is known to be responsible for cavitation effects in ultrasound [5]. Erbium-doped yttrium aluminium garnet, Q-switched ruby and carbon dioxide lasers have been used to increase skin permeability to drugs via ablation mechanism or lipid bilayer disruption in a process

Microwave

Microwave is a non-ionizing electromagnetic wave with wavelengths longer than those of terahertz waves, but relatively shorter than those of radiowaves [67]. It is characterized by frequencies between 300 MHz and 300 GHz. Broadly, the microwave is classified as ultra-high frequency (UHF) (0.3–3 GHz), super high frequency (SHF) (3–30 GHz) and extremely high frequency (EHF) (30–300 GHz) signals.

Microwave is generated by a magnetron which converts the electrical energy into an alternating

Conclusion

Iontophoretic delivery of lidocaine has been clinically approved for local anesthesia [15], [17]. High frequency ultrasound technique is used clinically to enhance transdermal delivery of steroids and anti-inflammatory drugs. The low frequency ultrasound technique has been developed and approved for topical lidocaine. The thermal technique has been tested in a number of human clinical trials on grainsetron, peptide fragment of human parathyroid hormone, insulin and human growth hormone [13],

Acknowledgment

The author wishes to thank REI UiTM for the given support during article preparation.

References (156)

  • T. Gratieri et al.

    Next generation intra- and transdermal therapeutic systems: using non- or minimally-invasive technologies to increase drug delivery into and across the skin

    Eur. J. Pharm. Sci.

    (2013)
  • S. Del Rio-Sancho et al.

    Transdermal absorption of memantine—effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity

    Eur. J. Pharm. Biopharm.

    (2012)
  • S. Mitragotri

    Devices for overcoming biological barriers: the use of physical forces to disrupt the barriers

    Adv. Drug Deliv. Rev.

    (2013)
  • R. Vanbever et al.

    In vivo efficacy and safety of skin electroporation

    Adv. Drug Deliv. Rev.

    (1999)
  • J. Cázares-Delgadillo et al.

    Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics

    Eur. J. Pharm. Biopharm.

    (2010)
  • Y.N. Kalia et al.

    Iontophoretic drug delivery

    Adv. Drug Deliv. Rev.

    (2004)
  • A. Djabri et al.

    Transdermal iontophoresis of ranitidine: an opportunity in paediatric drug therapy

    Int. J. Pharm.

    (2012)
  • S. Saluja et al.

    A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis

    Int. J. Pharm.

    (2013)
  • M.A. Calatayud-Pascual et al.

    Effect of iontophoresis on in vitro transdermal absorption of almotriptan

    Int. J. Pharm.

    (2011)
  • J. Raiman et al.

    Delivery and stability of LHRH and nafarelin in human skin: the effect of constant/pulsed iontophoresis

    Eur. J. Pharm. Sci.

    (2004)
  • R. Panchagnula et al.

    Transdermal iontophoresis revisited

    Curr. Opin. Chem. Biol.

    (2000)
  • J.P. Sylvestre et al.

    Iontophoresis of dexamethasone phosphate: competition with chloride ions

    J. Control. Release

    (2008)
  • K. Malinovskaja et al.

    Ion-exchange and iontophoresis-controlled delivery of apomorphine

    Eur. J. Pharm. Biopharm.

    (2013)
  • S. Dubey et al.

    Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1

    J. Control. Release

    (2011)
  • S.F. Taveira et al.

    Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity

    J. Control. Release

    (2009)
  • K. Tomoda et al.

    Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis

    Colloids Surf. B: Biointerfaces

    (2011)
  • K. Tomoda et al.

    Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo

    Colloids Surf. B: Biointerfaces

    (2012)
  • K. Tomoda et al.

    Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis

    Colloids Surf. B: Biointerfaces

    (2012)
  • O. Pillai et al.

    Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers

    Int. J. Pharm.

    (2004)
  • K.-C. Liu et al.

    Synergistic effect of chemical penetration enhancer and iontophoresis on transappendageal transport of oligodeoxynucleotides

    Int. J. Pharm.

    (2013)
  • B. Zorec et al.

    Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses

    Int. J. Pharm.

    (2013)
  • A.-R. Denet et al.

    Transdermal delivery of timolol by electroporation through human skin

    J. Control. Release

    (2003)
  • S. Tokumoto et al.

    Effect of electroporation on the electroosmosis across hairless mouse skin in vitro

    J. Control. Release

    (2005)
  • S. Tokumoto et al.

    Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin

    Int. J. Pharm.

    (2006)
  • Y. Wang et al.

    Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery

    Eur. J. Pharm. Biopharm.

    (2005)
  • E.A. Essa et al.

    Electrically assisted skin delivery of liposomal estradiol: phospholipid as damage retardant

    J. Control. Release

    (2004)
  • A. Sen et al.

    Transdermal insulin delivery using lipid enhanced electroporation

    Biochim. Biophys. Acta

    (2002)
  • Y. Tokudome et al.

    The synergic effects of various electrolytes and electroporation on the in vitro skin permeation of calcein

    J. Control. Release

    (2003)
  • Y. Tokudome et al.

    Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs

    J. Control. Release

    (2004)
  • G. Jiang et al.

    Transdermal drug delivery by electroporation: the effects of surfactants on pathway lifetime and drug transport

    Chin. J. Chem. Eng.

    (2007)
  • H. Chen et al.

    Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin

    J. Control. Release

    (2009)
  • B. Chen et al.

    Sonophoretic enhanced microneedle arrays (SEMA)—improving the efficiency of transdermal drug delivery

    Sensors Actuators B

    (2010)
  • B.E. Polat et al.

    Ultrasound-mediated transdermal drug delivery: mechanisms, scope and emerging trends

    J. Control. Release

    (2011)
  • A. Boucaud et al.

    Effect of sonication parameters on transdermal delivery of insulin into hairless rats

    J. Control. Release

    (2002)
  • S. Mitragotri et al.

    Low frequency sonophoresis: a review

    Adv. Drug Deliv. Rev.

    (2004)
  • L. Wolloch et al.

    The importance of microjet vs shock wave formation in sonophoresis

    J. Control. Release

    (2010)
  • D. Park et al.

    Sonophoresis in transdermal drug delivery

    Ultrasonics

    (2014)
  • C.M. Schoellhammer et al.

    Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound

    J. Control. Release

    (2012)
  • M. Mutoh et al.

    Characterization of transdermal solute transport induced by low-frequency ultrasound in the hairless rat skin

    J. Control. Release

    (2003)
  • F. Ahmadi et al.

    Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure

    Prog. Biophys. Mol. Biol.

    (2012)
  • Cited by (100)

    • Anti-aging peptides for advanced skincare: Focus on nanodelivery systems

      2023, Journal of Drug Delivery Science and Technology
    View all citing articles on Scopus
    View full text